Evidence map›Paper›PMID 41104979›Full record

ArticleMicrobial genomics2025

SeroBA(v2.0) and SeroBAnk: a robust genome-based serotyping scheme and comprehensive atlas of capsular diversity in

Oliver Lorenz, Alannah C King, Harry C H Hung, Feroze A Ganaie, Anne L Wyllie, Sam Manna, Catherine Satzke, Mark van der Linden, Neil Ravenscroft, Hans-Christian Slotved and 4 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microbial genomics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Oliver LorenzParasites and Microbes, The Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK.
Alannah C KingParasites and Microbes, The Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK.
Harry C H HungParasites and Microbes, The Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK.
Feroze A GanaieDivision of Pulmonary/Allergy/Critical Care, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Anne L WyllieDepartment of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut, USA.
Sam MannaInfection, Immunity, and Global Health, Murdoch Children's Research Institute, Melbourne, Australia.
Catherine SatzkeInfection, Immunity, and Global Health, Murdoch Children's Research Institute, Melbourne, Australia.
Mark van der LindenReference Laboratory for Streptococci, Department of Medical Microbiology, University Hospital RWTH Aachen, Aachen, Germany.
Neil RavenscroftDepartment of Chemistry, University of Cape Town, Rondebosch, South Africa.
Hans-Christian SlotvedDepartment of Science and Environment, Roskilde University, Roskilde, Denmark.
Lesley McGeeDivision of Bacterial Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Moon H NahmDivision of Pulmonary/Allergy/Critical Care, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Stephen D BentleyParasites and Microbes, The Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK.
Stephanie W LoParasites and Microbes, The Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK.

Funding

Serogroup 19 capsule maleability leading to vaccine failureR21AI178586 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI NAHM, MOON H. · 2023 to 2024
$408k
Gates Foundation INV-003570NIAID NIH HHS R21 AI178586Wellcome Trust
6 · The paper itself

Abstract

The unprecedented number of

Indexed as

Bacterial CapsulesGenome, BacterialSerotypingStreptococcus pneumoniaeComputational BiologyDatabases, GeneticGenetic VariationHumansPneumococcal InfectionsSerogroupSoftwaregenomic surveillancepneumococcusserotypingStreptococcus pneumoniaewhole-genome sequencing

Identifiers

PMID41104979
PMCPMC12534171

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.